Introduction {#sec1_1}
============

Abnormalities in cerebral haemodynamics, such as changes in local perfusion pressure and vascular integrity \[[@B1]\], are important pathophysiological elements in ischaemic stroke. The inadequate cerebral blood flow (CBF) supply may produce damage to neurons or glial cells beyond that caused by the initial ischaemia \[[@B1]\] due to either hypo- or hyperperfusion. The homeostatic balance in the human brain is regulated by two dynamic mechanisms called cerebral autoregulation (CA) and neurovascular coupling (NVC). In the normal brain, CA is a mechanism responsible for maintaining CBF relatively constant over a wide range of blood pressure (BP) variations. NVC refers to a cascade of events triggered by an increase in neuronal activity leading to an increase in CBF \[[@B2],[@B3]\]. Both mechanisms are challenged after acute ischaemic stroke \[[@B4],[@B5],[@B6]\].

Although previous studies have contributed greatly to our understanding of brain reorganization after cerebral ischemia, the influence of impaired haemodynamics on the improvement of clinical brain function over time is still unclear \[[@B4],[@B5],[@B6],[@B7]\]. Therefore, there is an urgent need to investigate the pattern of cerebral haemodynamic changes over time, with greater statistical power than is possible from cross-sectional studies. Previous longitudinal investigations of cerebral activity and/or cerebral regulation have been limited to two (the majority of studies) or three separate observations \[[@B6],[@B7],[@B8],[@B9],[@B10],[@B11],[@B12],[@B13],[@B14]\]. Epidemiological studies have suggested that the greatest amount of recovery occurs during the first 3 months after stroke onset \[[@B15]\].

Therefore, this prospective study aimed to investigate the temporal evolution of the changes in CBF regulation, assessing both CA and NVC mechanisms, within 72 h of acute ischaemic stroke onset, and at 3 additional time points over a 3-month recovery period. The first question addressed in this study was whether CBF regulation is impaired acutely within 72 h of stroke onset. A second question evaluated what the longitudinal changes of CBF regulation are during the recovery period, particularly the CBF velocity (CBFv) response to a passive motor paradigm.

Methods {#sec1_2}
=======

Participants {#sec2_1}
------------

Study participants were recruited from the Hyperacute Stroke Unit at the University Hospitals of Leicester NHS Trust. Inclusion criteria were as follows: (1) first episode of ischaemic stroke, confirmed by a single acute ischaemic brain lesion on MRI and/or CT, and (2) within 72 h of symptom onset. Exclusion criteria comprised: (1) history of neurological disorder; (2) atrial fibrillation, and (3) severe cognitive impairment that might prevent completion of the study. The Nottingham Research Ethics Committee 1, UK approved the research protocol (ref.: 11/EM/0016), and all study subjects gave informed consent before any study assessments.

Experimental Design {#sec2_2}
-------------------

The study protocols were planned as 3-month longitudinal investigations, during which patients underwent neurological and transcranial Doppler (TCD) assessments on 4 occasions after infarction occurred. Stroke participants were assessed in the acute phase (\<72 h) and at follow-up (2 weeks, and 1 and 3 months). A cross-sectional enrolment design also included a group of right-handed healthy controls matched for age and sex; handedness was established by the Edinburgh Inventory \[[@B16]\]. Neurological impairment and dependency were assessed utilizing the National Institutes of Health Stroke Scale \[[@B17]\] and the modified Rankin Scale \[[@B18]\], respectively.

Data Acquisition {#sec2_3}
----------------

The study was conducted in a quiet research laboratory with participants lying in a comfortable supine position. CBFv in the middle cerebral artery (MCA) was continuously assessed by TCD ultrasound (Viasys Companion III; Viasys Healthcare) using a dual 2-MHz transducer fitted to a head frame. BP and heart rate were continuously recorded by a Finapres device (Ohmeda 2300; Finapres, Louisville, Colo., USA) and 3-lead electrocardiogram, respectively. End-tidal CO~2~ (EtCO~2~) was monitored using a capnograph (Capnocheck Plus) with nasal sampling. All participants had abstained from caffeine, alcohol and nicotine for 2 h before the measurement.

After 15 min of stabilization, a 5-min baseline recording was taken, and the stimulation paradigm was then performed twice. This included a 90-second baseline phase, the paradigm performed over 60 s, and a 90-second recovery phase. The paradigm consisted of 1 min passive flexion and extension of the elbow, as described previously \[[@B19],[@B20],[@B21]\]. The rate of opposition was driven by a metronome (1 Hz), an electrical signal which marked the start and finish of the manoeuvre. Movement was performed only on the affected side in the stroke group and the dominant side (right) in controls.

Data Analysis {#sec2_4}
-------------

Data were simultaneously recorded onto a data acquisition system (Physidas, Department of Medical Physics, University Hospitals of Leicester) at a sampling rate of 500 samples/s. CBFv channels were filtered at 20 Hz (zero-phase eighth-order Butterworth), R-R interval was obtained using electrocardiogram, and mean BP, CBFv and EtCO~2~ were calculated for each cardiac cycle beat. Beat-to-beat data were spline interpolated and resampled at 5 Hz to produce signals with a uniform time base. The manoeuvre showing the largest CBFv response was chosen to represent the participant\'s response \[[@B19]\]. Mean CBFv, heart rate, BP and EtCO~2~ values were extracted from the 30 s preceding the paradigm for baseline comparisons. The beginning of stimulation was used as the point of synchronization to obtain population mean and SD curves for each variable and each hemisphere.

The CBFv step response to the BP input was computed on the 5-min baseline measurement, after a period of 100 s of stabilization, as previously described \[[@B22]\]. A fast Fourier transform was applied to the data, and the cross- and auto-spectra were estimated using the Welch method. The transfer function of the BP-CBFv dynamic relationship was then calculated with BP selected as the input, and right then left CBFv as the output variables. An inverse fast Fourier transform was then applied to the complex transfer function, converting data back into the time domain, to calculate the CBFv step response \[[@B22]\]. The autoregulatory index (ARI) was assigned to each recording by using the best least-squares fit between the CBFv step response and one of the 10 model ARI curves proposed by Tiecks et al. \[[@B23]\]. Values of ARI = 0 represent absence of CA, while values of ARI = 9 correspond to best-observed autoregulation. ARI was calculated for each subject for both hemispheres at baseline.

Using a standard protocol, responses obtained from the affected hemisphere (AH) in stroke were compared to the responses in the dominant hemisphere in the right-handed control population, whereas the unaffected hemisphere (UH) results were compared to the right hemisphere in controls \[[@B21]\].

Statistical Analysis {#sec2_5}
--------------------

Baseline CBFv values (5 min recording at rest and 30 s preceding the exercise performance) were compared using two-way ANOVA with group (control and patient) as the between factor and side of recording (right, left, AH, UH) as the within factor. A t test for independent samples was used to compare baseline values of heart rate, BP and EtCO~2~ between control and acute stroke participants (session 1). To compare the effect of the paradigms on CBFv and on peripheral haemodynamics, the area under the curve was calculated for their differences from the beginning of the manoeuvre up to 20 s after the end of the paradigm. Again, a t test for independent samples was used to compare heart rate, BP and EtCO~2~ area under the curve values between control and stroke groups (session 1), whereas a two-way ANOVA was used to compare CBFv area under the curve values. Repeated-measures ANOVA was used to assess the longitudinal data. Post hoc comparisons (Tukey\'s test) were performed when appropriate. Bonferroni correction was applied to multiple comparisons. A value of p \< 0.05 indicated statistical significance.

Results {#sec1_3}
=======

Participants\' Characteristics {#sec2_6}
------------------------------

A total of 15 acute stroke subjects underwent all 4 sessions of data collection and were compared to 22 controls. Two of the patients had total and 7 partial anterior circulation, and 6 had lacunar strokes according to the Oxfordshire Community Stroke Project classification \[[@B24]\]. Demographic and clinical characteristics of the participants are summarized in table [1](#T1){ref-type="table"}. The acute assessment (session 1) was undertaken a mean (SD) of 36.6 h (15.0) after the stroke onset, whereas the subacute (session 2) and chronic phases (sessions 3 and 4) were at 14.0 (1.0), 30.7 (1.2) and 94.2 days (0.7) after stroke, respectively.

Baseline Recordings {#sec2_7}
-------------------

Resting values of the recorded parameters during the 5-min and 30-second baseline periods are shown in table [2](#T2){ref-type="table"}. Though bilateral CBFv was lower in the stroke group during session 1 (\<72 h) than in the control group (two-way ANOVA group interaction, p = 0.03), only the AH CBFv was statistically lower than the left-hemisphere CBFv in controls (Tukey\'s p = 0.02). A gradual increase in the AH CBFv was seen on follow-up. On the other hand, the UH CBFv dropped at session 2 (decrease seen in 11/15 patients) which coincided with the drop in ARI values (table [2](#T2){ref-type="table"}; fig. [1](#F1){ref-type="fig"}). However, no statistical difference between assessments was found in the repeated-measures ANOVA. Stroke participants were consistently more hypertensive (p = 0.03), tachycardic (p = 0.009) and hypocapnic (p = 0.003) than controls showing the same pattern over time. Similar to the 5-min baseline values, the resting values of the affected CBFv, BP, heart rate and EtCO~2~ extracted from the 30 s preceding the passive elbow movement were significantly different between the stroke (session 1) and control groups (table [2](#T2){ref-type="table"}).

Passive Paradigm {#sec2_8}
----------------

A sharp bilateral increase in CBFv in response to the passive paradigm was observed in all subjects (fig. [2](#F2){ref-type="fig"}), but the rise was less pronounced in the stroke group except for the UH in session 3 (table [3](#T3){ref-type="table"}). Tukey\'s post hoc test revealed differences between left hemisphere and AH (p = 0.001), and between right hemisphere and UH (p = 0.05). Table [3](#T3){ref-type="table"} and figure [3](#F3){ref-type="fig"} illustrate the mean values of CBFv, BP, heart rate and EtCO~2~ for the first 80 s of the passive paradigm.

Discussion {#sec1_4}
==========

Main Findings {#sec2_9}
-------------

This study is the first to report the evolution of serial TCD assessments of CA and NVC mechanisms in the same stroke population followed over 3 months after stroke. In agreement with functional neural activation studies \[[@B10]\], the longitudinal responses of the CBFv to neural activation showed a triphasic trend from the acute to the chronic stage. The initially reduced bilateral CBFv response was followed by a CBFv increase in the UH after a month, which progressively approximated to the normal CBFv response pattern by 3 months. Other longitudinal studies have also shown signs of the progressive functional improvement of the CBF response or neural activation pattern in the stroke AH \[[@B8],[@B9],[@B12]\]. This observation is also consistent with findings from longitudinal studies in a rat stroke model in which functional improvement was accompanied by reactivation of the affected cortex over time \[[@B25]\].

In recent years, several investigators have found evidence for reorganization of the neural network after stroke, not only in the AH but also in the UH \[[@B12],[@B26],[@B27]\]. Moreover, overactivation of certain areas in the UH in the subacute phase was associated with clinical recovery \[[@B14],[@B28]\]. This is in line with our results, as the studied population all had a good recovery within weeks of stroke onset (table [1](#T1){ref-type="table"}) and the improved UH CBFv response was seen in the majority of participants by 1 month. The mechanisms of involvement of areas located in the UH seem to be effective not only in recovery from motor deficits \[[@B29],[@B30]\], but even in the favourable recovery of aphasia \[[@B31],[@B32]\].

Though CA impairment was not found acutely, a significant reduction in ARI was seen by 2 weeks, coinciding with a drop in baseline CBFv in the UH. The intra-individual time course of dynamic autoregulatory disturbance has not been extensively studied in humans from the first days after cerebral ischaemia. Previous studies analysing the CA in acute stroke found an impairment of dynamic CA \[[@B6],[@B13],[@B33]\] that lasted for at least 1-2 weeks \[[@B13]\]. This was associated with poor functional recovery \[[@B34]\].

There is always the possibility of the pressure-velocity relationship being strongly affected by changes in other physiological parameters like sympathetic activation, cerebral venous pressure, breathing frequency, and CO~2~ levels \[[@B35]\]. Because CO~2~ has a marked influence on CBFv and also on autoregulation itself, it is possible that the hypocapnia observed in the stroke patients has masked a modest CA impairment acutely. Further studies are needed to address this specific question.

In regions of poor perfusion pressure, arterioles are dilated and thus resistance is low; this results in impaired cerebrovascular reactivity (CVR) in these territories \[[@B36]\]. CVR was not assessed directly in this study, but our previous study used a two-parameter model to express the passive relationship between BP and CBFv comprised of critical closing pressure and resistance area product in the acute phase of stroke \[[@B37]\]. Critical closing pressure, which under certain conditions can represent the metabolic component of CA, was not affected after stroke, whilst resistance area product, which possibly represents the myogenic response, was impaired \[[@B37],[@B38],[@B39]\]. Therefore, the smaller CBFv response to neural activation in the acute phase and, as we may speculate, in the subacute phase as well could be (partially) attributed to a 'sluggish' vasodilatory response of the local vessels, as the vascular reserve was diminished but not entirely absent.

Physiological and Clinical Considerations {#sec2_10}
-----------------------------------------

The reason(s) for the bilateral impairment of CBF regulation, which seems to be limited to the acute and subacute phases, is (are) not clear. This phenomenon could be explained by arteriolar dysfunction that develops at the ischaemic site and spreads to remote areas later in the post-stroke phase \[[@B1]\]. It was hypothesized that a vicious circle could start in the peri-infarct area by spreading local acidosis, and this is amplified by reperfusion (either spontaneously or induced by thrombolysis) with consequent dysautoregulation \[[@B40]\]. In addition, bursts of oxidative stress induced by cerebral ischaemia lead to profound alterations in cerebrovascular regulation. In particular, reactive oxygen species can impair endothelial NO-mediated responses, vasodilation (mediated by K^+^ channel activation), and vasoconstrictor mechanisms \[[@B41]\]. Moreover, pre-existing endothelial dysfunction (due to ageing, internal carotid artery stenosis or hypertension), which may be exacerbated within the acute phase shortly after cortical ischaemic stroke \[[@B42]\], when inflammatory or autonomic changes additionally affect the cerebral vasculature, also need to be considered. An additional explanation relates to transhemispheric diaschisis, where CBF changes contralateral to the side of the ischaemic insult have been widely reported in the animal model and human literature. These studies suggest that CBF changes depend on the magnitude of the ischaemic insult, and gradually tend to return towards the baseline level more than a week after the ischaemic insult \[[@B43]\].

Adding to the complexity of the interpretation of post-stroke cerebral haemodynamic regulation, most patients showed a marked BP increase in all sessions compared to control subjects, though only 5 had a premorbid history of hypertension. Biochemical and structural changes triggered by sustained hypertension can also induce dysfunction of cerebral haemodynamic regulation \[[@B44]\]. Therefore, the sustained hypertension may have contributed to the CA deterioration in the subacute phase.

The evidence of NVC and CA impairment after ischaemic stroke demonstrated in this study and the failure of the myogenic component of CBF regulation in the acute phase shown in a previous study \[[@B24]\] might have implications for therapies directed at improvement of CBF regulation and perfusion. First, the role of BP becomes particularly important whenever a large volume of hypoperfused but still viable tissue, susceptible to changes in systemic BP, is present. The longitudinal findings revealed a deterioration of CA in the subacute phase being restored in the chronic phase. This adds to the debate on the acute use of antihypertensive therapy after stroke \[[@B45]\], particularly very intense BP lowering in all stroke subjects. Secondly, a randomized study demonstrated that aerobic treadmill training improves CVR in chronic stroke patients \[[@B46]\], which could also improve CA and NVC. Very few studies have investigated the evidence that exercise enhances CVR and to our knowledge, this hypothesis has not been tested in the earlier stages of stroke. In healthy subjects, exercise (hand grip and cycling) does not impair CA \[[@B47]\], but CA was affected during heavy (exhaustive) exercise \[[@B48]\]. While the state of CBF regulation after stroke is not yet fully understood, very early mobilization should be undertaken with caution, as an increase in BP in the presence of impaired CA and NVC may bring potential harm to the recovering brain, since CBF regulation might already be impaired and worsened during therapy leading to adverse events.

Limitations of the Study {#sec2_11}
------------------------

There are several limitations of the current study. The small number of patients reduced statistical power. More than half of the recruited stroke participants withdrew from the study after the first session mainly for reasons unrelated to the research protocol, such as being discharged to rehabilitation (n = 7) or undergoing carotid endarterectomy (n = 2). A range of circumstances further reduced the number of participants, such as the absence of temporal windows (n = 3). The protocol restrictions, particularly related to atrial fibrillation and survival to 3 months, imply that a population with mild-to-moderate stroke severity was recruited, as evidenced by the National Institutes of Health Stroke Scale scores. Therefore, these findings may not be generalizable to a more heterogeneous stroke population, meaning that an interesting hypothesis of the potential influence of stroke subtype could not be adequately explored. Moreover, it was not possible to assess the relevance of stroke sensorimotor deficits at around 2 weeks, because most cases recovered relatively well. Therefore, the longitudinal evolution of CBFv regulation for more severe stroke cases, with poor or limited recovery, still needs to be addressed.

The relatively small group of patients assessed did not allow us to distinguish between right and left hemisphere strokes, although the influence of hemisphere dominance on the CBF response is still not fully understood. Further studies are needed to perform separate analyses of patients with right and left lesions, which may be important given reported hemisphere predominance in autonomic control. In addition, a third of the studied stroke participants had a history of hypertension, whereas the control participants were all normotensive. Future studies will benefit from a second control group composed of non-stroke hypertensive subjects, in order to determine the separate contributions of stroke and hypertension.

There are also a number of acknowledged limitations associated with the use of TCD technology in the assessment of cerebral haemodynamics. First, there is a need for a transtemporal bone window, which is often compromised by age and/or bone thickening of the skull. Secondly, it only provides an assessment of global, usually MCA, hemispheric haemodynamic parameters, where focal changes, especially in the ischaemic penumbra, may be more informative following acute ischaemic stroke. Finally, TCD assesses CBFv, so any implied changes in CBF are consequent on a stable MCA diameter.

Conclusion {#sec1_5}
==========

The follow-up of a stroke population over a 3-month period, based on 4 sequential assessments of CA and NVC, showed that both mechanisms of CBFv regulation are impaired at some point during the first weeks after stroke onset, but return to control levels within 3 months. These findings are relevant to guide the timing of interventions to manipulate BP, and potentially for the impact of intensive rehabilitation strategies that may precipitate acute physiological perturbations, but require further exploration in a larger population that better reflects the heterogeneity of stroke, and will also enable the influence of stroke subtype to be investigated.
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![Mean values (±1 standard error) of ARI for healthy controls (R, L) and the stroke group. The stroke hemispheres are represented by affected (A) and unaffected (U), respectively, followed by the session number corresponding to \<72 h (1), 2 weeks (2), 1 month (3) and 3 months (4) of follow-up.](cee-0004-0186-g01){#F1}

![Population averages of CBFv in healthy controls and stroke at acute, subacute and chronic (1 and 3 months) time points during passive arm movement (duration indicated by grey bar). **a** Response to the right hemisphere of control subjects (continuous line) and to the UH in stroke patients during the acute (continuous line + symbol) and subacute (dashed line) phases. **b** Response to the right hemisphere of control subjects (continuous line) and to the UH in stroke patients during the chronic phases (1 month, continuous line + symbol; 3 months, dashed line). **c** Response to the left hemisphere of control subjects (continuous line) and to the AH in stroke patients during the acute (continuous line + symbol) and subacute (dashed line) phases. **d** Response to the left hemisphere of control subjects (continuous line) and to the AH in stroke patients during the chronic phases (1 month, continuous line + symbol; 3 months, dashed line). For clarity, only the largest ± 1 standard error is represented at the point of occurrence.](cee-0004-0186-g02){#F2}

![Mean values and standard error of BP (**a**), heart rate (**b**) and EtCO~2~ (**c**) for healthy controls and stroke group with the 4 sessions represented by S1 (\<72 h), S2 (2 weeks), S3 (1 month) and S4 (3 months), respectively.](cee-0004-0186-g03){#F3}

###### 

Participant characteristics

  Variables                                                 Stroke (n = 15)   Controls (n = 22)
  --------------------------------------------------------- ----------------- -------------------
  Age[^a^](#T1F1){ref-type="table-fn"}, years               62.4 ± 9.0        62.2 ± 7.5
  Male, n                                                   12                16
  Edinburgh Inventory[^a^](#T1F1){ref-type="table-fn"}, %   84.4 ± 6.2        89.9 ± 3.6
  Baseline medication                                                         
   Antihypertensive                                         4                 
   Statin                                                   1                 
  Hypertension                                              5                 --
  Myocardial infarction                                     2                 --
  Thrombolysis                                              2                 --
  Diabetes mellitus                                         0                 --
  Hypercholesterolaemia                                     1                 --
  Ipsilateral ICA stenosis                                                    
   \>50%                                                    1^b^              --
   30 -- 49%                                                1^b^              --
   \<30%                                                    1                 --
  Contralateral ICA stenosis                                                  
   30 -- 49%                                                2                 --
  Onset to assessment[^a^](#T1F1){ref-type="table-fn"}, h   36.6 ± 15.5       --
  NIHSS score[^a^](#T1F1){ref-type="table-fn"}                                
   Admission                                                7.8 ± 4.8         --
   Session 1                                                3.4 ± 1.9         --
   Session 2                                                1.9 ± 1.8         --
   Session 3                                                1.2 ± 1.6         --
   Session 4                                                0.7 ± 1.3         --
  mRS score[^a^](#T1F1){ref-type="table-fn"}                                  
   Session 1                                                2.1 ± 1.2         --
   Session 4                                                0.4 ± 0.5         --

ICA = Internal carotid artery; NIHSS = National Institutes of Health Stroke Scale; mRS = modified Rankin Scale.

Figures are given as means ± SD.

Ipsilateral and contralateral ICA stenosis.

###### 

Mean ± SD values for cerebral and peripheral haemodynamic variables during the 5 min baseline and the 30 s preceding the passive paradigm

  Variables                CBFv, cm·s^--1^   BP, mm Hg                                      HR, bpm                                        EtCO~2~, mm Hg                                 ARI                                                        
  ------------------------ ----------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ---------------------------------------------- ----------- -----------
  *5 min baseline*                                                                                                                                                                                                                                   
  Control                  48.9 ± 4.9        50.7 ± 5.6                                     87.2 ± 11.0                                    58.8 ± 8.0                                     37.7 ± 3.2                                     6.0 ± 0.9   5.7 ± 0.9
  Session 1                49.5 ± 10.1       45.4 ± 6.9[^\*^](#T2F1){ref-type="table-fn"}   91.9 ± 8.7[^\*^](#T2F1){ref-type="table-fn"}   65.3 ± 7.7[^\*^](#T2F1){ref-type="table-fn"}   35.1 ± 2.6[^\*^](#T2F1){ref-type="table-fn"}   5.6 ± 1.3   5.5 ± 1.3
  Session 2                43.9 ± 9.9        48.3 ± 8.6                                     93.7 ± 8.4                                     68.5 ± 10.3                                    35.6 ± 5.3                                     4.6 ± 1.3   4.7 ± 1.2
  Session 3                46.0 ± 6.1        48.8 ± 9.9                                     93.8 ± 9.6                                     64.3 ± 8.8                                     34.9 ± 2.1                                     5.1 ± 1.3   5.2 ± 1.8
  Session 4                47.9 ± 9.5        49.0 ± 9.8                                     94.8 ± 7.6                                     67.0 ± 9.3                                     35.4 ± 2.1                                     5.3 ± 1.0   5.6 ± 1.0
  *30 s before paradigm*                                                                                                                                                                                                                             
  Control                  49.5 ± 5.5        52.9 ± 5.0                                     87.2 ± 11.0                                    59.1 ± 7.6                                     39.1 ± 3.1                                                 
  Session 1                48.8 ± 8.0        47.1 ± 9.2[^\*^](#T2F1){ref-type="table-fn"}   93.6 ± 8.0[^\*^](#T2F1){ref-type="table-fn"}   67.9 ± 9.6[^\*^](#T2F1){ref-type="table-fn"}   34.8 ± 2.3[^\*^](#T2F1){ref-type="table-fn"}               
  Session 2                44.3 ± 9.6        47.3 ± 8.8                                     91.5 ± 7.6                                     64.9 ± 9.7                                     35.6 ± 3.4                                                 
  Session 3                45.7 ± 8.0        48.1 ± 9.6                                     91.7 ± 7.5                                     65.4 ± 10.0                                    35.8 ± 3.2                                                 
  Session 4                48.6 ± 8.9        49.2 ± 8.9                                     91.7 ± 7.6                                     64.6 ± 10.3                                    36.1 ± 2.3                                                 

HR = Heart rate.

p \< 0.02 (Tukey\'s post hoc test) for the comparison between stroke (session 1) and control.

###### 

Mean ± SD values of the CBFv response, BP, heart rate and EtCO~2~ responses to passive paradigm for patients (sessions 1--4) and controls

  Variables   CBFv, %          BP, mm Hg                                       HR, bpm       EtCO~2~, mm Hg   
  ----------- ---------------- ----------------------------------------------- ------------- ---------------- ------------
  Control     107.8 ± 6.2      108.3 ± 5.5                                     90.5 ± 10.5   60.7 ± 8.0       38.8 ± 3.0
  Session 1   105.4 ± 5.3      104.1 ± 4.9[^\*^](#T3F1){ref-type="table-fn"}   94.1 ± 9.3    69.8 ± 10.9      34.6 ± 2.4
  Session 2   105.5 ± 4.3      104.9 ± 2.9                                     92.2 ± 10.1   69.4 ± 11.7      35.5 ± 2.7
  Session 3   110.0 ± 6.9^¥^   107.0 ± 4.7                                     91.4 ± 8.9    64.8 ± 10.4      35.9 ± 3.2
  Session 4   105.9 ± 5.8      106.4 ± 4.8                                     90.9 ± 8.1    64.3 ± 12.8      36.3 ± 2.3

HR = Heart rate.

p \< 0.01 (Tukey\'s post hoc test) for the differences between control (left hemisphere) and stroke (AH; session 1) groups.^¥^ p \< 0.04 (Tukey\'s post hoc test; not significant after Bonferroni correction) between sessions 1 and 3, between sessions 2 and 3, and between sessions 3 and 4.
